Literature DB >> 15664536

Donepezil for memory impairment in multiple sclerosis.

Maria Pia Amato1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15664536     DOI: 10.1016/S1474-4422(05)00972-5

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  5 in total

1.  The Effects of Cognitive Rehabilitation on Relapsing Remitting Multiple Sclerosis Patients.

Authors:  İlknur Güçlü Altun; Dursun Kirbaş; Deniz Utku Altun; Aysun Soysal; Pakize Nevin Sütlaş; Demet Yandim Kuşçu; Neslihan Behrem Gayir; Ekim Arslan; Barış Topçular
Journal:  Noro Psikiyatr Ars       Date:  2015-06-01       Impact factor: 1.339

Review 2.  Treatment options of cognitive impairment in multiple sclerosis.

Authors:  Francesco Patti; Carmela Leone; Emanuele D'Amico
Journal:  Neurol Sci       Date:  2010-11       Impact factor: 3.307

Review 3.  Sexual dysfunction in patients with multiple sclerosis: a multidisciplinary approach to evaluation and management.

Authors:  Sophie G Fletcher; Wanda Castro-Borrero; Gina Remington; Katherine Treadaway; Gary E Lemack; Elliot M Frohman
Journal:  Nat Clin Pract Urol       Date:  2009-02

4.  A high throughput drug screening assay to identify compounds that promote oligodendrocyte differentiation using acutely dissociated and purified oligodendrocyte precursor cells.

Authors:  Karen D Lariosa-Willingham; Elen S Rosler; Jay S Tung; Jason C Dugas; Tassie L Collins; Dmitri Leonoudakis
Journal:  BMC Res Notes       Date:  2016-09-05

5.  Development of a high throughput drug screening assay to identify compounds that protect oligodendrocyte viability and differentiation under inflammatory conditions.

Authors:  Karen D Lariosa-Willingham; Elen S Rosler; Jay S Tung; Jason C Dugas; Tassie L Collins; Dmitri Leonoudakis
Journal:  BMC Res Notes       Date:  2016-09-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.